Sofinnova Venture Partners X, L.P.'s Net Worth
Estimate Recalculated Nov 1, 2024 11:27AM EST
Who is Sofinnova Venture Partners X, L.P.
Sofinnova Venture Partners X, L.P. has an estimated net worth of $112 Million. This is based on reported shares across multiple companies, which include , Vera Therapeutics, Inc., Aerovate Therapeutics, Inc., Inozyme Pharma, Inc., Bolt Biotherapeutics, Inc., and Akouos, Inc..
SEC CIK
Sofinnova Venture Partners X, L.P.'s CIK is 0001680200
Past Insider Trading and Trends
2021 was Sofinnova Venture Partners X, L.P.'s most active year for acquiring shares with 7 total transactions. Sofinnova Venture Partners X, L.P.'s most active month to acquire stocks was the month of January. 2021 was Sofinnova Venture Partners X, L.P.'s most active year for disposing of shares, totalling 4 transactions. Sofinnova Venture Partners X, L.P.'s most active month to dispose stocks was the month of January. 2021 saw Sofinnova Venture Partners X, L.P. paying a total of $21,999,980.00 for 9,427,899 shares, this is the most they've acquired in one year. In 2020 Sofinnova Venture Partners X, L.P. cashed out on 42,575,697 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
